Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome.
Anna V MathewLei LiJaeman ByunYanhong GuoGeorge MichailidisMamta JaiswalY Eugene ChenPradipta R RaySubramaniam PennathurPublished in: Diabetes care (2018)
In summary, TLCs improved HDL function by inhibiting MPO-mediated oxidative stress even before appreciable changes in HDL levels.